Literature DB >> 1899963

Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.

H Asakura1, H Jokaji, M Saito, C Uotani, I Kumabashiri, E Morishita, M Yamazaki, T Matsuda.   

Abstract

Plasma levels of tissue-plasminogen activator.plasminogen activator inhibitor (t-PA.PAI) complex and active PAI were assayed in 58 cases of disseminated intravascular coagulation (DIC). A significant elevation of both parameters was observed in most cases of DIC, especially in patients with non-Hodgkin lymphoma, sepsis, or some patients with acute leukemia, but no such elevation was observed in patients with acute promyelocytic leukemia (APL). The levels of both parameters were higher in cases of DIC with multiple organ failure (MOF) than in those without MOF. Since no elevation of t-PA.PAI complex was observed in most cases of APL, t-PA did not seem to play an important role in the activation of fibrinolytic system in APL. Active PAI, which reflects the inhibitory regulation in fibrinolytic system, was considered to play a role in the progression of MOF. Plasma levels of active PAI were low in the cases of APL, which had no complication of MOF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899963     DOI: 10.1002/ajh.2830360304

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Authors:  Anna Krasnodembskaya; Gianluca Samarani; Yuanlin Song; Hanjing Zhuo; Xiao Su; Jae-Woo Lee; Naveen Gupta; Mario Petrini; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

2.  Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.

Authors:  Juanzhen Li; Jingyi Zhou; Hong Ren; Teng Teng; Biru Li; Ying Wang; Long Xiang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Authors:  J Schneiderman; M S Sawdey; M R Keeton; G M Bordin; E F Bernstein; R B Dilley; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.

Authors:  M Hoshino; Y Haraguchi; H Hirasawa; M Sakai; H Saegusa; K Hayashi; N Horita; H Ohsawa
Journal:  Crit Care       Date:  2001-02-26       Impact factor: 9.097

Review 5.  Classifying types of disseminated intravascular coagulation: clinical and animal models.

Authors:  Hidesaku Asakura
Journal:  J Intensive Care       Date:  2014-03-06

Review 6.  Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.

Authors:  Shinya Yamada; Hidesaku Asakura
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.